| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/02/2003 | US20030004209 Anti-angiogenic compositions and methods of use |
| 01/02/2003 | US20030004196 Antiinflamamtory agents; autoimmune disease |
| 01/02/2003 | US20030004162 Antidiabetic agents; dietetics |
| 01/02/2003 | US20030004152 Method of treating sexual disturbances |
| 01/02/2003 | US20030004146 Compositions for preventing hormone induced adverse effects |
| 01/02/2003 | US20030004133 Wound healing agents, antiulcer agents |
| 01/02/2003 | US20030004124 Modulation of apoptosis with nucleic acids; anticancer agents, central nervous system disorders |
| 01/02/2003 | US20030004122 Anticancer agents |
| 01/02/2003 | US20030004121 Supplying hybrid protein to central nervous system |
| 01/02/2003 | US20030004120 Apoptosis; antitumor, anticancer agents |
| 01/02/2003 | US20030004119 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/02/2003 | US20030004114 Method of inhibiting fungal growth |
| 01/02/2003 | US20030004113 Autoimmune disease; rheumatic disorders |
| 01/02/2003 | US20030004112 Cell-permeable protein inhibitors of calpain |
| 01/02/2003 | US20030004111 Bax fragment induced tumor cell death |
| 01/02/2003 | US20030004110 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/02/2003 | US20030004109 Leptin/ob receptor having a WSX motif |
| 01/02/2003 | US20030004108 TGF-beta to improve neural outcome |
| 01/02/2003 | US20030004107 Method of preventing cell death using segments of neural thread proteins |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030004105 Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction |
| 01/02/2003 | US20030004103 Modulators of activity of G-protein-coupled receptor kinases |
| 01/02/2003 | US20030004102 Genetic engineering; immunosuppressants, anticancer agents |
| 01/02/2003 | US20030004101 Alzheimer's disease |
| 01/02/2003 | US20030004100 Method of modifying the release profile of sustained release compositions |
| 01/02/2003 | US20030004099 The use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/02/2003 | US20030004098 Polypeptide; purification by chromatography |
| 01/02/2003 | US20030004096 Polypeptide mixture containing preservative, surfactant and stabilizer |
| 01/02/2003 | US20030004095 Treatment of diabetes with milk protein hydrolysate |
| 01/02/2003 | US20030004092 Methods and agents for inducing apoptosis and methods for their identification |
| 01/02/2003 | US20030003579 Dendritic cells; methods |
| 01/02/2003 | US20030003576 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 01/02/2003 | US20030003567 Packaging cells |
| 01/02/2003 | US20030003564 Modulation of ubiquitin proteolysis; obtain sample containind enzymatic complexes, incubate with sample, monitor cleavage activity |
| 01/02/2003 | US20030003559 Nucleotide sequences coding polypeptide for use in the treatment of diabetes, kidney, and liver disorders |
| 01/02/2003 | US20030003556 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| 01/02/2003 | US20030003555 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 01/02/2003 | US20030003546 Treating degenerative cartilaginous disorders and other inflammatory diseases |
| 01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
| 01/02/2003 | US20030003542 ACPL polypeptides |
| 01/02/2003 | US20030003538 Neuropathic pain genes; compositions thereof; related reagents |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030003530 Nucleotide sequences coding protein for use in diagnosis and treatment of skin and cancer disorders |
| 01/02/2003 | US20030003488 Organelle enzymatic polypeptide for use in the treatment of tumors |
| 01/02/2003 | US20030003482 Diagnosing skin disorders and diabetic injury; obtain sample, incubate with probe detect and determine gene expression concentration of preferential gene, amplified gene expression indicates skin disorder |
| 01/02/2003 | US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders |
| 01/02/2003 | US20030003469 Ribozyme treatment of diseases or conditions related to levels of NF-kappaB |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003451 Novel G protein-coupled receptors |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/02/2003 | US20030003444 R9Detection of preferential polypeptide in sample; obtain sample of polypeptide, incubate with bacteriophage, monitor adjustment in activity, adjustment in activity |
| 01/02/2003 | US20030003440 Immunogenic peptide for use in the detection and prevention of viral diseases |
| 01/02/2003 | US20030003163 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 01/02/2003 | US20030003150 System for osmotic delivery of pharmaceutically active agents |
| 01/02/2003 | US20030003141 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited |
| 01/02/2003 | US20030003123 A substance/species active with respect to the trophicity of the cutaneous nerves and/or neurostimulant and/or neuroactivator and/or neuromediator, formulated into cosmetically, or dermatologically acceptable vehicle, diluent |
| 01/02/2003 | US20030003117 Hydrolyzed whole egg products & related methods |
| 01/02/2003 | US20030003114 Hexosaminidase covalently attached to a cancer cell targeting ligand; improves selectively of the hexosaminidase for tumor cells |
| 01/02/2003 | US20030003111 Having amino acid sequence which differs from amino acid sequence of a major surface antigen of a wild type hepatitis B virus in that the amino acid at position number 133 of such polypeptide is a threonine rather than a methionine |
| 01/02/2003 | US20030003108 Diagnosis and treatment of hepatic disorders |
| 01/02/2003 | US20030003103 Sequences for targeting metastatic cells |
| 01/02/2003 | US20030003101 Treatment and diagnosis of prostate cancer |
| 01/02/2003 | US20030003099 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection |
| 01/02/2003 | US20030003098 Treating graft with molecule which binds to co-stimulatory protein of antigen-presenting cells |
| 01/02/2003 | US20030003096 Only specifically binds activated factor VII, and not factor VII, and does not bind to an activated factor VII which is complexed with antithrombin III |
| 01/02/2003 | US20030003094 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 01/02/2003 | US20030003092 Administering an immunotherapeautic agent in conjunction with a tumour growth restricting agent, in amounts effective to eradicate any advanced or large tumours present |
| 01/02/2003 | US20030003091 Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract |
| 01/02/2003 | US20030003087 Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system |
| 01/02/2003 | US20030003085 Drug delivery of a muscle protein by administering purified donor muscle side population cells; gene therapy, in the treatment muscle diseases muscular dystrophies, genetic diseases, treating cancer, and bone marrow transplant |
| 01/02/2003 | US20030003082 Use of poly-Glu,Tyr and T cells treated therewith for neuroprotective therapy |
| 01/02/2003 | US20030003081 A nutritional supplement contains an ubiquinone bound with a glycoprotein matrix |
| 01/02/2003 | US20030003079 Recombinant pox virus for immunization against tumor-associated antigens |
| 01/02/2003 | US20030003077 A genetic engineered adenoviral vector contains an adenoviral genome from which the open reading frames E1 and/or E3 were deleted and a therapeutic gene or a DNA sequence that encodes for therapeutic proteins useful in fibrosis treatment |
| 01/02/2003 | US20030003076 Adenovirus E1B-55K single amino acid mutants and methods of use |
| 01/02/2003 | US20030003075 Ameliorant for hepatitis C therapeutic effect and application thereof |
| 01/02/2003 | US20030003074 Comprising a biodegradable block copolymeric drug carrier having thermally reversible gelation properties; sustained release of an interleukin-2, no side effects |
| 01/02/2003 | US20030003047 Tumor radiotherapy |
| 01/02/2003 | US20030000519 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 01/02/2003 | EP1271153A2 Collapsin response mediator protein-1 as tumor metastasis marker |
| 01/02/2003 | EP1271146A1 Method and composition of cellular reprogramming |
| 01/02/2003 | EP1270732A1 Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 01/02/2003 | EP1270726A1 69624, a human transporter family member and uses therefor |
| 01/02/2003 | EP1270724A2 Guanosine triphosphate-binding protein coupled receptors |
| 01/02/2003 | EP1270723A1 Anticomplement polyptide from salivary glands of the tick Ixodes ricinus |
| 01/02/2003 | EP1270642A1 Branched polyalkylene glycols |
| 01/02/2003 | EP1270594A1 Antibodies to peptide from a soluble fragment of acetylcholinesterase |
| 01/02/2003 | EP1270590A1 Human CD24-like protein and nucleic acids encoding it |
| 01/02/2003 | EP1270589A1 Novel leukotriene b4 receptor |
| 01/02/2003 | EP1270588A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 01/02/2003 | EP1270586A2 Composition for the cell-specific transfer of active substances |
| 01/02/2003 | EP1270585A1 Peptide derivative |
| 01/02/2003 | EP1270577A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 01/02/2003 | EP1270032A1 Device for parenterally delivering solid drug compositions |
| 01/02/2003 | EP1270030A1 Adsorbents for dilated cardiomyopathy |
| 01/02/2003 | EP1270015A2 A complex comprising OCIF and Polysaccharide |
| 01/02/2003 | EP1270013A1 Topical wound healing compositions comprising hyaluronic acid and a serine protease inhibitor |
| 01/02/2003 | EP1270012A1 Use of pulmonary administration of insulin for treatment of diabetes |
| 01/02/2003 | EP1270011A1 Drugs for ameliorating impaired glucose tolerance |